Ra Pharmaceuticals Inc
(RARX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2016 | 12-2015 | 09-2015 | 12-2014 | |
| Sales | 1,884 | 0 | 1,096 | 0 |
| Gross Profit | 1,884 | N/A | 1,096 | N/A |
| Operating Expenses | 6,248 | 0 | 4,566 | 0 |
| Operating Income | -4,364 | N/A | -3,470 | N/A |
| Interest Expense | 0 | 0 | 14 | 0 |
| Other Income | -692 | 0 | -448 | 0 |
| Pre-tax Income | -5,056 | 0 | -3,932 | 0 |
| Net Income Continuous | -5,056 | N/A | -3,932 | N/A |
| Net Income | $-5,056 | $N/A | $-3,932 | $N/A |
| EPS Basic Total Ops | -9.42 | N/A | -4.57 | N/A |
| EPS Basic Continuous Ops | -9.42 | N/A | -7.95 | N/A |
| EPS Diluted Total Ops | -9.42 | N/A | -4.57 | N/A |
| EPS Diluted Continuous Ops | -9.42 | N/A | -7.95 | N/A |
| EBITDA(a) | $-4,093 | $N/A | $-3,470 | $N/A |